Concepedia

Ophelia W. Hadjilambris

OW

Statistics

Publications

6

Citations

166

H-Index

6

Active since

1992

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Ophelia W. Hadjilambris is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, clinical pharmacology, and molecular biology.

Publications per year

1992–2001

6

Publications

6

The Pharmacokinetics of Irbesartan in Hypertensive Children and Adolescents

Abdullah Şakarcan, Frank Tenney, John T. Wilson et al. · The Journal of Clinical Pharmacology · 2001 · 80 citations

, , +17

Mutational Analysis of the Endothelin Type A Receptor (ET<sub>A</sub>):  Interactions and Model of the Selective ET<sub>A</sub>Antagonist BMS-182874 with the Putative ET<sub>A</sub>Receptor Binding Cavity

Maria L. Webb, Pramathesh S. Patel, Patricia M. Rose et al. · Biochemistry · 1996 · 21 citations

, , +17

Glycosylation of Active Human Renin Is Necessary for Secretion: Effect of Targeted Modifications of Asn-5 and Asn-75

Victoria Rothwell, Steven G. Kosowski, Ophelia W. Hadjilambris et al. · DNA and Cell Biology · 1993 · 20 citations

, , +14

Irbesartan Does Not Affect the Pharmacokinetics of Simvastatin in Healthy Subjects

Maria R. Marino, Nimish N. Vachharajani, Ophelia W. Hadjilambris · The Journal of Clinical Pharmacology · 2000 · 20 citations

, , +13

The Pharmacokinetics and Pharmacodynamics of Irbesartan in Heart Failure

John B. Kostis, N. Vachharajani, Ophelia W. Hadjilambris et al. · The Journal of Clinical Pharmacology · 2001 · 15 citations

, , +17

1–5 of 6